Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Prescription Drug Prices
Vermont: First State to Pass Pharmaceutical Cost Transparency Bill
Vermont is soon to be the first state in the nation that requires pharmaceutical manufacturers to explain the reasons…
Campaign for Sustainable Rx Pricing Holds Forum
The Campaign for Sustainable Rx Pricing (CSRxP) held a forum on "market-based policy solutions to curb rising drug prices" at the…
Bipartisan Policy Center Holds Panel Discussion on Drug Pricing
The Bipartisan Policy Center has plans to host three educational forums over the next several months, focused on the…
IMS Releases 2016 Report on Prescription Drug Spending – Net Price Growth…
The IMS Institute for Healthcare Informatics released its annual Medicines Use and Spending in the U.S. report.…
American College of Physicians Calls on Federal Government to Regulate…
Late last year, we reported on the AMA's House of Delegates vote to adopt several recommendations in support of…
Washington State Convenes Task Force on Drug Prices
"Don't stop trying" that is the theme of the Washington State legislature as overrode a governor's veto to push through…
Panel Discussion on Medicare Part B Drug Payment Model Demonstration
In an effort to support the CMS proposed changes to Medicare Part B drug reimbursement, the Pew Charitable Trust held a…
MedPAC Meeting on Part B Drug Payment Policy
The Medicare Payment Advisory Commission held a meeting on Part B drug payment policy issues. The meeting focused on the…
Specialty Pricing Drugs: How Did We Get Here and Where Do We Go
The American Enterprise Institute recently published a research publication on specialty drug pricing. The publication,…
CMS Proposed Rule Drastically Changes the Way Medicare Pays for Part B…
The Centers for Medicare and Medicaid Services announced their proposal to test new Medicare Part B prescription drug…